Engineering HIV virus-like-particles (VLPs) for improved Env antigenicity and neutralizing antibody responses.
Engineering HIV virus-like-particles (VLPs) for improved Env antigenicity and neutralizing antibody responses.
批准号:
403720
负责人:
Mann Jamie F
金额:
$39.29万
依托单位国家:
加拿大
项目类别:
Operating Grants
财政年份:
2019
资助国家:
加拿大
项目状态:
已结题
起止时间:
2019-03-01 至 2024-03-01
中文摘要
点击翻译按钮获取中文摘要
英文摘要
HIV-1 is the etiological agent behind the global HIV epidemic.It is acknowledged that an efficacious anti-HIV vaccine remain the best hope for eliminating the HIV-1 epidemic. However, the failure to produce effective vaccine immunogens and the inability o
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Evaluating the HIV cellular reservoir in preclinical and Phase 1 clinical trial samples after latency reversal with activator vaccines.
-
批准号:351865
-
项目类别:Operating Grants
-
资助金额:$7.29万
-
财政年份:2016
-
负责人:Mann Jamie F
-
依托单位:
海外基金